DNAprint Genomics (DNAG)

[ole vern]

Froggie,

Though we all are now curious as to which
drug company you are associated with, I won't
ask, as I would not want to be asked. But may
I ask if your company relies heavily on genomics
in its drug-discovery program? As you know, the
FDA has not made any hard and fast rules requiring
a genomics tie-in in all drug-discovery though they
are highly recommending it.

When the FDA is presented with a NDA accompanied by
a genomics-supported program, what do they do if they
have no established system set up to evaluate these
genomics programs? Or have all their scientists had
to go back to school to become more fluent in genomics?
Even so, I suppose they just have to examine closely
every aspect of each offering and see how it supports
itself, especially with regard to reproducibility.

One more question if I may ask. Does the work of
DNAPrint impinge at all on your company?

Though I have been angered by much you have said
against DNAPrint, nevertheless I am more and more
impressed by your knowledge.

Thanks for any enlightenment.